Business Description
Shanghai Medicilon Inc
ISIN : CNE100003NQ8
Compare
Compare
Traded in other countries / regions
688202.China IPO Date
2019-11-05Description
Shanghai Medicilon Inc is a comprehensive biomedical research and developemnt service company. It provides a full range of one-stop new drug development services for pharmaceutical companies and research institutions around the world in line with domestic and international reporting standards.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.43 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.27 | |||||
| Debt-to-EBITDA | 1.24 | |||||
| Interest Coverage | 48.26 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 8.78 | |||||
| Beneish M-Score | -0.94 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 42.8 | |||||
| 3-Year EBITDA Growth Rate | 55.7 | |||||
| 3-Year EPS without NRI Growth Rate | 58.8 | |||||
| 3-Year FCF Growth Rate | -104.8 | |||||
| 3-Year Book Growth Rate | 17.2 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.55 | |||||
| 9-Day RSI | 43.17 | |||||
| 14-Day RSI | 40.97 | |||||
| 6-1 Month Momentum % | -25.57 | |||||
| 12-1 Month Momentum % | -49.54 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.73 | |||||
| Quick Ratio | 1.49 | |||||
| Cash Ratio | 0.27 | |||||
| Days Inventory | 60.95 | |||||
| Days Sales Outstanding | 113.44 | |||||
| Days Payable | 68.21 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.54 | |||||
| Dividend Payout Ratio | 0.14 | |||||
| Forward Dividend Yield % | 0.54 | |||||
| 5-Year Yield-on-Cost % | 0.53 | |||||
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | -1.93 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 38.68 | |||||
| Operating Margin % | 22.05 | |||||
| Net Margin % | 19.11 | |||||
| ROE % | 21.37 | |||||
| ROA % | 14.82 | |||||
| ROIC % | 20.35 | |||||
| ROC (Joel Greenblatt) % | 31.3 | |||||
| ROCE % | 21.99 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 25.28 | |||||
| PE Ratio without NRI | 25.28 | |||||
| Price-to-Owner-Earnings | 55.09 | |||||
| PEG Ratio | 0.57 | |||||
| PS Ratio | 4.82 | |||||
| PB Ratio | 4.97 | |||||
| Price-to-Tangible-Book | 6.03 | |||||
| EV-to-EBIT | 26.36 | |||||
| EV-to-EBITDA | 26.36 | |||||
| EV-to-Revenue | 5.52 | |||||
| EV-to-FCF | -23.91 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.03 | |||||
| Price-to-Graham-Number | 2.61 | |||||
| Price-to-Net-Current-Asset-Value | 19.69 | |||||
| Earnings Yield (Greenblatt) % | 3.78 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shanghai Medicilon Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,788.38 | ||
| EPS (TTM) (Â¥) | 2.799 | ||
| Beta | 1.4 | ||
| Volatility % | 38.46 | ||
| 14-Day RSI | 40.97 | ||
| 14-Day ATR (Â¥) | 3.195247 | ||
| 20-Day SMA (Â¥) | 73.0835 | ||
| 12-1 Month Momentum % | -49.54 | ||
| 52-Week Range (Â¥) | 67.81 - 204.735714 | ||
| Shares Outstanding (Mil) | 134.51 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shanghai Medicilon Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shanghai Medicilon Inc Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shanghai Medicilon Inc Frequently Asked Questions
What is Shanghai Medicilon Inc(SHSE:688202)'s stock price today?
The current price of SHSE:688202 is ¥71.46. The 52 week high of SHSE:688202 is ¥204.74 and 52 week low is ¥67.81.
When is next earnings date of Shanghai Medicilon Inc(SHSE:688202)?
The next earnings date of Shanghai Medicilon Inc(SHSE:688202) is .
Does Shanghai Medicilon Inc(SHSE:688202) pay dividends? If so, how much?
The Dividend Yield %  of Shanghai Medicilon Inc(SHSE:688202) is 0.54% (As of Today), Highest Dividend Payout Ratio of Shanghai Medicilon Inc(SHSE:688202) was 0.35. The lowest was 0.14. And the median was 0.25. The  Forward Dividend Yield % of Shanghai Medicilon Inc(SHSE:688202) is 0.54%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers